BlackRock
VIVO

BlackRock’s Meridian Bioscience Inc VIVO Stock Holding History

BlackRock’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,558,212
Closed -$251M – 5824
2022
Q4 		$251M Buy
7,558,212
+237,937
+3% +$7.66M 0.01% 1368
2022
Q3 		$231M Buy
7,320,275
+96,045
+1% +$3.11M 0.01% 1361
2022
Q2 		$220M Sell
7,224,230
-144,830
-2% -$3.92M 0.01% 1454
2022
Q1 		$191M Sell
7,369,060
-36,865
-0.5% -$877K 0.01% 1711
2021
Q4 		$151M Buy
7,405,925
+120,338
+2% +$2.31M ﹤0.01% 1939
2021
Q3 		$140M Sell
7,285,587
-127,024
-2% -$2.53M ﹤0.01% 1982
2021
Q2 		$164M Buy
7,412,611
+480,066
+7% +$10.2M ﹤0.01% 1921
2021
Q1 		$182M Buy
6,932,545
+84,798
+1% +$2.02M 0.01% 1797
2020
Q4 		$128M Buy
6,847,747
+118,612
+2% +$2.21M ﹤0.01% 1922
2020
Q3 		$114M Buy
6,729,135
+69,216
+1% +$1.35M ﹤0.01% 1802
2020
Q2 		$155M Buy
6,659,919
+89,430
+1% +$1.3M 0.01% 1540
2020
Q1 		$55.2M Sell
6,570,489
-335,720
-5% -$2.83M ﹤0.01% 1987
2019
Q4 		$67.5M Buy
6,906,209
+360,867
+6% +$3.39M ﹤0.01% 2185
2019
Q3 		$62.1M Buy
6,545,342
+87,997
+1% +$927K ﹤0.01% 2162
2019
Q2 		$76.7M Buy
6,457,345
+140,424
+2% +$1.69M ﹤0.01% 2077
2019
Q1 		$111M Buy
6,316,921
+21,261
+0.3% +$354K 0.01% 1817
2018
Q4 		$109M Buy
6,295,660
+67,044
+1% +$1.14M 0.01% 1731
2018
Q3 		$92.8M Buy
6,228,616
+327,584
+6% +$5.08M ﹤0.01% 2021
2018
Q2 		$93.8M Buy
5,901,032
+518,731
+10% +$7.74M ﹤0.01% 1981
2018
Q1 		$76.4M Buy
5,382,301
+109,220
+2% +$1.62M ﹤0.01% 2016
2017
Q4 		$73.8M Buy
5,273,081
+97,242
+2% +$1.42M ﹤0.01% 2049
2017
Q3 		$74M Buy
5,175,839
+64,634
+1% +$923K ﹤0.01% 2039
2017
Q2 		$80.5M Sell
5,111,205
-31,018
-0.6% -$447K ﹤0.01% 1947
2017
Q1 		$71M Buy
5,142,223
+5,137,397
+106,452% +$71.8M ﹤0.01% 2008
2016
Q4 		$86K Sell
4,826
-984
-17% -$17.3K ﹤0.01% 2652
2016
Q3 		$112K Buy
5,810
+395
+7% +$7.73K ﹤0.01% 2519
2016
Q2 		$105K Buy
5,415
+1,560
+40% +$30.6K ﹤0.01% 2508
2016
Q1 		$80K Buy
3,855
+2,359
+158% +$46.5K ﹤0.01% 2106
2015
Q4 		$31K Buy
1,496
+290
+24% +$5.56K ﹤0.01% 2350
2015
Q3 		$20K Hold
1,206
– – ﹤0.01% 2401
2015
Q2 		$23K Sell
1,206
-79
-6% -$1.47K ﹤0.01% 2340
2015
Q1 		$24K Hold
1,285
– – ﹤0.01% 2283
2014
Q4 		$21K Hold
1,285
– – ﹤0.01% 2354
2014
Q3 		$23K Hold
1,285
– – ﹤0.01% 2264
2014
Q2 		$27K Sell
1,285
-91
-7% -$1.87K ﹤0.01% 2236
2014
Q1 		$30K Hold
1,376
– – ﹤0.01% 2163
2013
Q4 		$36K Hold
1,376
– – ﹤0.01% 2056
2013
Q3 		$33K Hold
1,376
– – ﹤0.01% 2016
2013
Q2 		$30K Buy
+1,376
New +$29.7K ﹤0.01% 2089

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BlackRock's VIVO Position: Q1 2023 in Review

BlackRock sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 7,558,212 shares — an estimated $251M sold.

BlackRock first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $251M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • BlackRock reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • BlackRock sold 7,558,212 Meridian Bioscience Inc shares in Q1 2023, an estimated $251M.
  • BlackRock first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • BlackRock's Meridian Bioscience Inc position peaked at $251M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.